MedTrace Logo

Urologic-nephrological Care of Chronic Kidney Disease in Saxony-Anhalt/Magdeburg.

NCT02229435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1031336

Last updated 2014-09-01

No results posted yet for this study

Summary

Statement:

Patients with Chronic kidney disease (CKD) with an estimated glomerular filtration rate (eGFR) under 60 ml/min using the MDRD-6 (Modification of Diet in Renal Disease) formula and/or CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula should undergo nephrological and urological care (diagnosis and treatment) to prevent chronic kidney failure. This is recommended by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI), Kidney Disease Improving Global Outcomes (KDIGO) and European Urological Association (EAU). Renal and postrenal diseases can cause or worsen CKD. Internistic and intrarenal diseases can caused or worsen CKD. All diseases affecting CKD should be treated and the medical care should be optimized.

Hypothesis:

Not all patients with CKD receive urological and nephrological care. Interdisciplinary work of outpatient working urologists and nephrologists in the metropolitan area Magdeburg / Saxony-Anhalt Germany is unknown. An descriptive analysis of interdisciplinary treatment connection of CKD patients for an orientating statement is needed.

Conditions

  • Chronic Kidney Disease (CKD)

Sponsors & Collaborators

  • Medical Laboratory Schenk-Ansorge Magdeburg Germany.

    collaborator UNKNOWN

  • University of Magdeburg

    lead OTHER

Principal Investigators

  • Johann J Wendler, Dr. · Urology University Magdeburg

  • Martin Schostak, Prof. Dr. · Urology University Magdeburg

  • Herwart Schenk, Prof. Dr. · Medical Laboratory Am Neustädter Feld 47, 39124 Magdeburg, Saxony-Anhalt, Germany.

  • Constanze Tienken, Cand. med. · Doctorand Urology University Magdeburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229435 on ClinicalTrials.gov